Clinical Trial Update: Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients

View source ↗

Summary

A completed open registry study evaluating how genomic testing influences treatment choices for patients with prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Myriad Genetic Laboratories, Inc. | Conditions: Prostate Cancer | Status: COMPLETED